All are true about gantacurium-except
**Core Concept**
Gantacurium is a non-depolarizing neuromuscular blocking agent that works by competitively blocking acetylcholine receptors at the neuromuscular junction. It is a bis-quaternary compound that is rapidly metabolized by plasma cholinesterase.
**Why the Correct Answer is Right**
Gantacurium is a non-depolarizing neuromuscular blocker that competitively blocks acetylcholine receptors at the neuromuscular junction. This prevents acetylcholine from binding to its receptors and inducing muscle contraction, resulting in muscle paralysis. The bis-quaternary structure of gantacurium allows it to effectively block acetylcholine receptors, making it a potent neuromuscular blocker.
**Why Each Wrong Option is Incorrect**
**Option A:** This option may be incorrect because gantacurium is actually a non-depolarizing neuromuscular blocker, not a depolarizing one. Depolarizing blockers, such as succinylcholine, work by activating acetylcholine receptors, whereas non-depolarizing blockers, like gantacurium, block acetylcholine receptors.
**Option B:** This option may be incorrect because gantacurium's mechanism of action is not based on the inhibition of acetylcholinesterase, but rather on the competitive blockade of acetylcholine receptors.
**Option C:** This option may be incorrect because gantacurium is actually a rapid-onset neuromuscular blocker, not a long-acting one. Its rapid onset of action is due to its rapid metabolism by plasma cholinesterase.
**Option D:** This option may be incorrect because gantacurium is not a bis-benzylisoquinolinium compound, but rather a bis-quaternary compound.
**Clinical Pearl / High-Yield Fact**
Gantacurium's rapid metabolism by plasma cholinesterase makes it a potentially useful agent in patients with renal failure, where other neuromuscular blockers may accumulate to toxic levels.
**Correct Answer: A. Gantacurium is a depolarizing neuromuscular blocker.**